Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
cancer
deals
ipo
cancer immunotherapy
fda
gene therapy
medicare
startups
venture capital
abbvie
What
bio
roundup
new
ipo
life
millions
remains
science
talk
years
acquisitions
allogene
announced
approval
bails
becker
billions
biogen’s
biopharmaceutical
brand
bridgebio
cancer
capital
car
ceo
collabs
companies
convo
covid
crispr
daniel
deal
develop
diversity
dollars
drug
drugs
earlier
eaton
emerges
Language
unset
Current search:
crispr
×
biotech
×
" san diego blog main "
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More